Skip to main content

News

June 15, 2020
Targeted chemo is feasible, safe, and may improve quality of life.
December 18, 2018
Adjuvant transarterial chemoembolization was associated with improved outcomes in patients with hepatocellular carcinoma and microvascular invasion, but tumor size affected efficacy.
December 17, 2018
A new study showed the long-term results of and patient satisfaction with trapezius ports in breast cancer patients is associated with high overall patient satisfaction, providing a safe and feasible alternative site to chest ports.
December 17, 2018
The introduction of computer assisted targeting solutions and efficient ablation modalities helped one high-volume center achieve excellent reproducible results as well as minimize operator dependency.
December 13, 2018
Artificial intelligence (AI) is the future of clinical data management with the potential to aid in the intersection between complex data and clinical decision making. Given AIs ability to rapidly analyze big data, interventional radiologists can…
December 09, 2018
At the time of percutaneous transhepatic portal vein embolization (PVE), hyperbilirubinemia has no apparent effect on future liver remnant (FLR) hypertrophy, according to a new study.
December 05, 2018
Transcatheter arterial chemoembolization (TACE) combined with apatinib prolonged time to progression and overall survival compared to TACE-alone for Barcelona Clinic Liver Cancer stage C HCC, according to a study published in BMC Cancer.
December 02, 2018
Long-term survival in patients with massive hepatocellular carcinomas was improved when treatment consisted of transcatheter arterial chemoembolization (TACE) combined with percutaneous microwave coagulation therapy compared with TACE alone.
November 26, 2018
No significant difference in overall survival and liver cancer-specific survival was found in patients with localized hepatocellular carcinoma treated with either cryoablation or radiofrequency ablation, according to a new study.
November 19, 2018
Transarterial radioembolization with yttrium-90 (TARE-Y90) of unresectable primary liver malignancy demonstrates an anticancer effect and could be used as adjunctive therapy in pediatric patients with unresectable hepatic malignancies.
November 19, 2018
Endovascular denervation can improve pain in patients with abdominal cancer and may offer a new approach to palliative care, according to a new study.
Back to Top